Mirum Pharmaceuticals Inc (STU:08D)
€ 38.8 0.6 (1.57%) Market Cap: 1.92 Bil Enterprise Value: 1.95 Bil PE Ratio: 0 PB Ratio: 8.72 GF Score: 52/100

Q1 2021 Mirum Pharmaceuticals Inc Earnings Call Transcript

May 06, 2021 / 08:30PM GMT
Operator

Welcome to the Mirum Pharmaceuticals Q1 Earnings Call. My name is Rees, and I will be your operator for today's call. (Operator Instructions) I will now turn the call over to Ian Clements. Ian, you may begin.

Please standby as we are experiencing technical difficulties. Again, please stand by one moment, please.

Ian Clements
Mirum Pharmaceuticals, Inc. - CFO

Hello, Rees, can you hear us now?

Operator

Hello. Yes, I can. My apologies for the technical error.

Ian Clements
Mirum Pharmaceuticals, Inc. - CFO

Thanks, Rees. I'll take you from the top. Apologies, everyone, for the technical snap through there. So thanks for joining us. As I mentioned, we -- I'm joined today by our President and CEO, Chris Peetz, our Chief Operating Officer, Peter Radovich.

Earlier this afternoon, Mirum issued a news release announcing company's results for the quarter ended March 31, 2021. Copies of this news release and SEC filings can be found in the Investors section of our website.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot